Am J Transplant, Volume 21, Suppl 3 Archives - Page 60 of 139 - ATC Abstracts

2021 American Transplant Congress
Quantifying the Interaction Between Posaconazole and Tacrolimus in Liver Transplant Recipients: A Practical Approach
B. Lane¹, U. Kaszubski¹, A. Freeman¹, B. Wise¹, L. Hutchinson¹, M. Janusek¹, G. Therapondos², H. Bohorquez³, S. Anders¹
¹Pharmacy, Ochsner Medical Center, New Orleans, LA, ²Hepatology, Ochsner Medical Center, New Orleans, LA, ³Transplant Surgery, Ochsner Medical Center, New Orleans, LA
*Purpose: The interaction between tacrolimus (FK) and posaconazole (POSA) is well documented, however the extent of this interaction and the practical management has yet to…
2021 American Transplant Congress
Effects of TIPS on Transplant Outcomes for HCC
C. L. Hanlon¹, D. Toy¹, Y. Liu¹, S. Zhou¹, K. Zhou², J. Kahn², L. Yuan²
¹Internal Medicine, University of Southern California, Los Angeles, CA, ²Internal Medicine - Department of Gastroenterology and Hepatology, University of Southern California, Los Angeles, CA
*Purpose: The purpose of this study is to examine effects of TIPS placement on response to locoregional therapy (LRT) and clinical outcomes after liver transplantation…
2021 American Transplant Congress
The Landscape of Non-Directed Living Liver Donation in the United States
L. R. Herbst, L. Zeiser, A. Massie, K. Herrick Reynolds, E. King, A. Gurakar, D. L. Segev, J. Garonzik Wang, A. M. Cameron
Johns Hopkins University, Baltimore, MD
*Purpose: Non-directed donation (NDD) for kidney transplantation has increased substantially over the past decade, however the landscape of NDD for liver transplantation has yet not…
2021 American Transplant Congress
Marginal Allografts in Liver Transplantation Have Very Limited Impact on Length of Stay
C. Goff¹, T. Zhang¹, M. McDonald¹, A. Anand¹, N. Galvan², F. Kanwal³, G. Cholankeril², R. Hernaez³, J. A. Goss⁴, A. Rana²
¹Department of Student Affairs, Baylor College of Medicine, Houston, TX, ²Division of Abdominal Transplantation, Michael E DeBakey Department of General Surgery, Baylor College of Medicine, Houston, TX, ³Division of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, TX, ⁴Liver Center, Division of Abdominal Transplantation, Department of General Surgery, Baylor College of Medicine, Houston, TX
*Purpose: The purpose of this study was to determine the effect on recipient length of hospital stay following transplantation with marginal allografts as specified by…
2021 American Transplant Congress
Patient Feedback of a Patient and Family Decision Support Tool for Liver Organ Offer Decisions
C. Schaffhausen¹, S. Chu², M. Bruin³, S. Chinnakotla³, J. Lake³, A. Israni⁴
¹Hennepin Healthcare Research Institute, Minneapolis, MN, ²University of Minnesota (UMN), Minneapolis, MN, ³UMN, Minneapolis, MN, ⁴Hennepin Healthcare, UMN, Minneapolis, MN
*Purpose: For liver transplant candidates on the waiting list, deciding to accept a donor organ with known or potential risk factors can be stressful and…
2021 American Transplant Congress
Paired Surveillance Biopsies Over >4 Years from a Multi-Center Cohort of 78 Long-Term Pediatric Liver Transplant Recipients
E. R. Perito¹, E. Persyn², J. Bucuvalas³, J. E. Squires⁴, M. Martinez⁵, S. Mohammad⁶, A. J. Demetris⁴, S. Feng¹
¹UCSF, San Francisco, CA, ²King's College, London, United Kingdom, ³Mt. Sinai School of Medicine, NY, NY, ⁴U of Pittsburgh, Pittsburgh, PA, ⁵Columbia U, NY, NY, ⁶Northwestern U, Chicago, IL
*Purpose: Progressive liver fibrosis threatens graft and patient longevity for children after liver transplantation (LT). Previous studies are limited to single-center, cross-sectional analyses. To address…
2021 American Transplant Congress
Therapeutic Enoxaparin Dosing in Lung Transplant Recipients
S. Finder, M. Morrison, K. B. Harrison, S. A. Heeney
Vanderbilt University Medical Center, Nashville, TN
*Purpose: Enoxaparin 1 mg/kg subcutaneously every 12 hours for therapeutic anticoagulation is known to increase rates of supratherapeutic anti-Xa levels in lung transplant recipients (LTRs).…
2021 American Transplant Congress
Incidentally Detected Malignancies in Lung Explants: Single Center Case Series
D. Razia, A. Arjuna, L. Schaheen, J. Huang, M. Smith, R. Bremner, R. Walia
Thoracic Surgery and Lung Transplantation, Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ
*Purpose: Thoracic malignancies are difficult to prospectively diagnose in patients with end-stage lung disease due to complex radiologic features. We present a series of lung…
2021 American Transplant Congress
Impact of Bacterial Infection on HLA Allosensitization Among Kidney Recipients on the Waitlist
D. P. Cina¹, K. R. Sherwood², S. Dobrer², J. Wong³, F. Fenninger², M. Kadatz⁴, P. Keown⁴, J. Lan⁴
¹Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada, ²University of British Columbia, Vancouver, BC, Canada, ³Department of Laboratory Medicine, Vancouver General Hospital, Vancouver, BC, Canada, ⁴Department of Nephrology, University of British Columbia, Vancouver, BC, Canada
*Purpose: The clinical relevance of HLA allosensitization associated with bacterial infection remains poorly defined. The primary objective of this study is to determine the incidence,…
2021 American Transplant Congress
Association of Obesity and Early Post Kidney Transplantation Complications
V. Sandra, N. Sanichar, D. Tsapepas, K. L. King, J. Van Bever, K. Toma, A. Hussain, S. Mohan
Columbia University Irving Medical Center, New York, NY
*Purpose: Although the prevalence of obesity among kidney transplant recipients is rising, there continues to be reluctance to waitlist obese candidates. We sought to determine…